DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,677,342 | +4.5% | 135,741 | +1.0% | 3.91% | +11.0% |
| Q2 2023 | $32,240,880 | -4.0% | 134,337 | +0.8% | 3.52% | -13.3% |
| Q1 2023 | $33,590,379 | -8.4% | 133,274 | -3.5% | 4.06% | -16.6% |
| Q4 2022 | $36,663,792 | +2.5% | 138,135 | -0.3% | 4.86% | +0.1% |
| Q3 2022 | $35,779,000 | +0.4% | 138,522 | -1.5% | 4.86% | +5.0% |
| Q2 2022 | $35,640,000 | -27.1% | 140,582 | -5.4% | 4.63% | +4.5% |
| Q1 2022 | $48,877,000 | 0.0% | 148,558 | 0.0% | 4.43% | 0.0% |
| Q4 2021 | $48,877,000 | +4.3% | 148,558 | -3.5% | 4.43% | -0.7% |
| Q3 2021 | $46,845,000 | +11.7% | 153,873 | -1.5% | 4.46% | +11.5% |
| Q2 2021 | $41,921,000 | +19.0% | 156,211 | -0.2% | 4.00% | +10.1% |
| Q1 2021 | $35,226,000 | -0.6% | 156,503 | -1.9% | 3.63% | -2.0% |
| Q4 2020 | $35,453,000 | +4.0% | 159,597 | +0.8% | 3.70% | -10.9% |
| Q3 2020 | $34,103,000 | +16.8% | 158,374 | -4.1% | 4.16% | +10.3% |
| Q2 2020 | $29,196,000 | +27.0% | 165,108 | -0.6% | 3.77% | +2.1% |
| Q1 2020 | $22,984,000 | -10.3% | 166,056 | -0.5% | 3.69% | +7.0% |
| Q4 2019 | $25,609,000 | +5.9% | 166,858 | -0.4% | 3.45% | -3.3% |
| Q3 2019 | $24,193,000 | +0.9% | 167,508 | -0.2% | 3.57% | +1.0% |
| Q2 2019 | $23,988,000 | +5.4% | 167,843 | -2.6% | 3.53% | -3.1% |
| Q1 2019 | $22,761,000 | +26.9% | 172,404 | -0.9% | 3.64% | +13.9% |
| Q4 2018 | $17,934,000 | -5.1% | 173,916 | +0.0% | 3.20% | +12.8% |
| Q3 2018 | $18,889,000 | +8.0% | 173,834 | -1.9% | 2.84% | +3.2% |
| Q2 2018 | $17,482,000 | +0.5% | 177,154 | -0.3% | 2.75% | +1.2% |
| Q1 2018 | $17,394,000 | +4.4% | 177,649 | -1.0% | 2.72% | +2.8% |
| Q4 2017 | $16,663,000 | +7.5% | 179,523 | -0.6% | 2.64% | +1.5% |
| Q3 2017 | $15,499,000 | +2.0% | 180,688 | +0.4% | 2.61% | -0.5% |
| Q2 2017 | $15,190,000 | -1.8% | 180,003 | -0.5% | 2.62% | -4.3% |
| Q1 2017 | $15,470,000 | +11.1% | 180,868 | +1.1% | 2.74% | +4.1% |
| Q4 2016 | $13,923,000 | -1.0% | 178,868 | -0.3% | 2.63% | -2.1% |
| Q3 2016 | $14,068,000 | -22.0% | 179,463 | +0.5% | 2.68% | -21.9% |
| Q2 2016 | $18,035,000 | +5.7% | 178,563 | -0.7% | 3.44% | +5.7% |
| Q1 2016 | $17,065,000 | +1.2% | 179,898 | -0.9% | 3.25% | -1.4% |
| Q4 2015 | $16,855,000 | +8.3% | 181,468 | -0.6% | 3.30% | -11.4% |
| Q3 2015 | $15,559,000 | -0.1% | 182,593 | +0.3% | 3.72% | +4.5% |
| Q2 2015 | $15,576,000 | +0.9% | 181,983 | +0.1% | 3.56% | +0.3% |
| Q1 2015 | $15,436,000 | +0.3% | 181,818 | +1.3% | 3.55% | -0.6% |
| Q4 2014 | $15,383,000 | +12.5% | 179,483 | -0.3% | 3.57% | +2.9% |
| Q3 2014 | $13,674,000 | -5.0% | 179,973 | -1.6% | 3.47% | -2.5% |
| Q2 2014 | $14,399,000 | +2.6% | 182,888 | -2.3% | 3.56% | +0.8% |
| Q1 2014 | $14,035,000 | -7.8% | 187,138 | -5.1% | 3.53% | -8.2% |
| Q4 2013 | $15,229,000 | +10.1% | 197,263 | -1.2% | 3.85% | +4.5% |
| Q3 2013 | $13,835,000 | +8.6% | 199,588 | -0.8% | 3.68% | +0.6% |
| Q2 2013 | $12,739,000 | – | 201,253 | – | 3.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |